AbClon Inc (174900.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea · ISIN KR7174900001
AbClon Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.34 bn KRW | 4.71 bn KRW |
| Gross profit | 1.08 bn KRW | 1.14 bn KRW |
| Operating income | -15.59 bn KRW | -17.64 bn KRW |
| EBIT | -15.40 bn KRW | -17.47 bn KRW |
| Net income | -16.30 bn KRW | -17.91 bn KRW |
| Diluted EPS – continuing operations | -935.52 KRW | -898.70 KRW |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AbClon Inc
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. The company's products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers. AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.
More stocks
- Universal Vision Biotechnology Co Ltd (3218.TWO)
- Guangdong Jushen Logistics Co Ltd (001202.SZ)
- Hangzhou Gisway Information Technology Co. Ltd. A (301390.SZ)
- WhiteFiber, Inc. (WYFI)
- Selvaag Bolig ASA (SBO.OL)
- Chengdu Shengbang Seals Co.Ltd. (301233.SZ)
- Village Farms International, Inc. (VFF)
- Autolus Therapeutics plc (AUTL)
- John Marshall Bancorp, Inc. (JMSB)
- Guolin Environmental Tech Co Ltd (300786.SZ)
- Taiwan Optical Platform Co Ltd (6464.TW)
- Guangdong Hongxing Industrial Co. Ltd. (001209.SZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.